Session Information
AABB Audioconference Series 2012
Click here to go to the previous page
The Future of Bone Marrow vs HPC
Track
:
Technical/Clinical
Program Code:
124697
Date:
Wednesday, March 14, 2012
Time:
2:00 PM to 3:30 PM
EST
DIRECTOR
:
Dr. Meghan Delaney, DO, MPH, Medical Director, Seattle Children's Hospital
MODERATOR
(S):
Dennis Confer, MD, Chief Medical Officer, National Marrow Donor Program
Dr. Meghan Delaney, DO, MPH, Medical Director, Seattle Children's Hospital
SPEAKER
:
Dennis Confer, MD, Chief Medical Officer, National Marrow Donor Program
Description
How are hematopoetic stem cells from a bone marrow collection different from those collected using apheresis from peripheral blood? Does the method of stem cell collection affect patient outcomes? Details specific to both types of collections, as well as outcomes that may be related to the stem cell source, will be discussed.
- Describe how the hematopoetic stem cell source (bone marrow or peripheral blood stem cells) may affect transplant patient outcomes.
- Describe the different methods for hematopoetic stem cell collection.
- Describe the side effects to the hematopoetic stem cell donor and their relation to the type of donation.
| CE Category | CE Value |
|---|---|
| California Clinical Laboratory Personnel | 1.5 |
| California Nurse | 1.8 |
| Florida Laboratory Personnel | 1.8 |
| General Attendee | 1.5 |
| Physician | 1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
 | Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or reproduction of any materials herein is strictly prohibited. |  |